Key result
Sugammadex administration in an 8-month-old child with complex congenital heart disease resulted in a 10-minute bradycardic arrest.
Why the study?
Sugammadex-induced bradycardia is considered benign in healthy children, but data on its potential to cause severe bradycardic arrest in pediatric patients with heart disease are limited.
Does sugammadex administration cause bradycardic arrest in children with complex congenital heart disease?
Case Report (n=1)
Does sugammadex administration cause bradycardic arrest in children with complex congenital heart disease?
Sugammadex administration to children with heart disease may cause hemodynamically significant bradycardia and cardiac arrest.
No takes yet. Share an insight, caveat, or question.
Alerts to possible sugammadex-associated bradycardia in infants with CHD; single case leaves open incidence and causality.
Vaswani et al. (2023) conducted a case report in Complex congenital heart disease (n=1). Sugammadex was evaluated on Bradycardic arrest. Sugammadex administration in an 8-month-old child with complex congenital heart disease resulted in a 10-minute bradycardic arrest.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: